Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic landscape of endometrial carcinomas of no specific molecular profile
Amir Momeni Boroujeni, Bastien Nguyen, Chad Vanderbilt, et al.
Modern Pathology (2022) Vol. 35, Iss. 9, pp. 1269-1278
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 7, pp. 1360-1368
Open Access | Times Cited: 87
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives
Damiano Arciuolo, Antonio Travaglino, Antonio Raffone, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11684-11684
Open Access | Times Cited: 79
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
Amy Jamieson, Jutta Huvila, Derek S. Chiu, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100085-100085
Open Access | Times Cited: 53
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
Eric Rios‐Doria, Amir Momeni Boroujeni, Claire F. Friedman, et al.
Gynecologic Oncology (2023) Vol. 174, pp. 262-272
Open Access | Times Cited: 46
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
Natalia Galant, Paweł Krawczyk, Marta Monist, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5893-5893
Open Access | Times Cited: 15
New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere
Ilan Bruchim, Ilaria Capasso, Ariel Polonsky, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 1-2, pp. 29-43
Closed Access | Times Cited: 9
Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
Wei Chen, Yan Lü, Qin Li, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Update in the molecular classification of endometrial carcinoma
Alicia León‐Castillo
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 333-342
Open Access | Times Cited: 20
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
Sarah Ehmann, Dib Sassine, Alli Straubhar, et al.
Gynecologic Oncology (2022) Vol. 167, Iss. 3, pp. 458-466
Open Access | Times Cited: 24
Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
Christian Dagher, Beryl Manning‐Geist, Lora H. Ellenson, et al.
Gynecologic Oncology (2023) Vol. 179, pp. 180-187
Open Access | Times Cited: 15
Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping
Aaron Praiss, Christian Dagher, Qin Zhou, et al.
Gynecologic Oncology (2024) Vol. 191, pp. 37-44
Closed Access | Times Cited: 6
Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms
A. Lightfoot Stan, Korey Bosart, Mehak Kaur, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0299114-e0299114
Open Access | Times Cited: 5
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation
Beryl Manning‐Geist, Eric Rios‐Doria, Ying L. Liu, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 5, pp. 697-704
Closed Access | Times Cited: 5
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer
Elisa D’Agostino, Luciana Mastrodomenico, Ornella Ponzoni, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102723-102723
Closed Access | Times Cited: 5
Copy number variations in endometrial cancer: from biological significance to clinical utility
Erica Dugo, Francesco Piva, Matteo Giulietti, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 7, pp. 1089-1097
Closed Access | Times Cited: 5
Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols
Zihui Yang, Xi Yang, Xinyu Liu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups
Lina Irshaid, Danielle C. Costigan, Fei Dong, et al.
Modern Pathology (2023) Vol. 36, Iss. 5, pp. 100123-100123
Open Access | Times Cited: 12
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance
Mohd Nazzary Mamat Yusof, Kah Teik Chew, Nirmala Chandralega Kampan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15233-15233
Open Access | Times Cited: 12
Mesonephric‐like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix
F. Kommoss, Cheng‐Han Lee, Basile Tessier‐Cloutier, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 1, pp. 4-9
Open Access | Times Cited: 12
New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles
Masanori Yasuda
Pathology International (2024) Vol. 74, Iss. 10, pp. 557-573
Open Access | Times Cited: 4
Low-Risk and High-Risk NSMPs: A Prognostic Subclassification of No Specific Molecular Profile Subtype of Endometrial Carcinomas
Matteo Marchetti, Giulia Spagnol, Tommaso Vezzaro, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3221-3221
Open Access | Times Cited: 4
The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype
Amy Jamieson, Naveena Singh, Jutta Huvila, et al.
Gynecologic Oncology (2023) Vol. 171, pp. 159-161
Closed Access | Times Cited: 10
Advances in the management of endometrial cancer
Bradley R. Corr, Britt Erickson, Emma L. Barber, et al.
BMJ (2025), pp. e080978-e080978
Closed Access
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer
Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, et al.
Gynecologic Oncology (2025) Vol. 197, pp. 43-50
Closed Access
Page 1 - Next Page

Scroll to top